Please assess the completion status of the following clinical trial:

Trial Title: Smoking Termination Opportunity for inPatients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Smoker of at least 10 cigarettes per day on average over the past 12 months~* Inpatient with an anticipation admission of at least one day~* Willingness to quit smoking~* Aged between 20 and 75 years~* A plan of discharge to go home~* Acute hospital admission with cardiovascular, cerebrovascular, peripheral vascular diseases or airways (asthma and/or Chronic Obstructive Pulmonary disease~Exclusion Criteria:~* Subject preference to use an alternative pharmacotherapy for smoking cessation~* Respiratory patient being considered for home oxygen~* Pregnancy~* Breast feeding~* Acute or pre-existing severe psychiatric illnesses~* Past history of psychosis or suicidal ideation~* Renal impairment with creatinine clearance \<30ml/min

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Champix plus counselling (Type: EXPERIMENTAL): varenicline tartrate will be initiated whilst subjects are inpatients with the standard MIMS dosing schedule (including period of titration). In combination with Quit SA (5A) telephone counselling service
- counselling alone (Type: ACTIVE_COMPARATOR): 5A counselling via Quit SA (quitline) telephone counselling service. (maximum 8 phone calls per subject within a 3 month period).

Based on this trial design, predict the completion outcome and termination type (if applicable).